Published in J Magn Reson Imaging on December 13, 2012
Ultra-high field magnetic resonance imaging of the basal ganglia and related structures. Front Hum Neurosci (2014) 0.84
Simultaneous in vivo spectral editing and water suppression. NMR Biomed (1998) 5.09
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A (1993) 2.77
Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol (2010) 2.21
In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med (2001) 2.12
The role of GABA in human motor learning. Curr Biol (2011) 2.03
Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med (2007) 1.91
In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc (2011) 1.91
GABA, gamma-hydroxybutyric acid, and neurological disease. Ann Neurol (2003) 1.91
Diurnal stability of gamma-aminobutyric acid concentration in visual and sensorimotor cortex. J Magn Reson Imaging (2010) 1.86
Brain GABA editing without macromolecule contamination. Magn Reson Med (2001) 1.75
Regionally specific human GABA concentration correlates with tactile discrimination thresholds. J Neurosci (2011) 1.61
Baseline GABA concentration and fMRI response. Neuroimage (2010) 1.59
More GABA, less distraction: a neurochemical predictor of motor decision speed. Nat Neurosci (2010) 1.54
A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging (2007) 1.49
Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry (2004) 1.42
Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol (2003) 1.41
Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biol Psychiatry (2010) 1.38
Efficient γ-aminobutyric acid editing at 3T without macromolecule contamination: MEGA-SPECIAL. NMR Biomed (2011) 1.34
Direct in vivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magn Reson Med (2002) 1.31
Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7 T: T2 relaxation times and concentrations of cerebral metabolites. NMR Biomed (2011) 1.29
Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla. Magn Reson Med (2007) 1.28
GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res (2009) 1.25
Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry (1999) 1.25
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.16
Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects. Magn Reson Med (2005) 1.15
Biological and clinical MRS at ultra-high field. NMR Biomed (1997) 1.11
Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry (2003) 1.04
High-field proton MRS of human brain. Eur J Radiol (2003) 0.90
Efficient spectral editing at 7 T: GABA detection with MEGA-sLASER. Magn Reson Med (2011) 0.89
The European Nucleotide Archive. Nucleic Acids Res (2010) 6.48
Improvements to services at the European Nucleotide Archive. Nucleic Acids Res (2009) 5.00
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci U S A (2009) 3.31
Re-examining the brain regions crucial for orchestrating speech articulation. Brain (2004) 3.23
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial. Lancet Oncol (2012) 2.98
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial. Lancet Oncol (2013) 2.94
Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology (2013) 2.79
Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J Clin Oncol (2013) 2.69
Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke (2003) 2.61
Individual differences in subconscious motor control predicted by GABA concentration in SMA. Curr Biol (2010) 2.21
Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences. Neuroimage (2006) 2.21
The GUDMAP database--an online resource for genitourinary research. Development (2011) 2.20
Major submissions tool developments at the European Nucleotide Archive. Nucleic Acids Res (2011) 1.94
Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med (2006) 1.94
Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med (2007) 1.91
Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med (2006) 1.91
In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc (2011) 1.91
Impaired tactile processing in children with autism spectrum disorder. J Neurophysiol (2014) 1.81
Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet (2003) 1.80
In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.78
Anatomy of spatial attention: insights from perfusion imaging and hemispatial neglect in acute stroke. J Neurosci (2005) 1.75
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). J Clin Oncol (2012) 1.73
Regionally specific human GABA concentration correlates with tactile discrimination thresholds. J Neurosci (2011) 1.61
Restoring cerebral blood flow reveals neural regions critical for naming. J Neurosci (2006) 1.60
Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci (2006) 1.59
Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2002) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging (2013) 1.57
Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes (2011) 1.55
In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med (2007) 1.55
More GABA, less distraction: a neurochemical predictor of motor decision speed. Nat Neurosci (2010) 1.54
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav (2011) 1.53
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
Individual variability in the shape and amplitude of the BOLD-HRF correlates with endogenous GABAergic inhibition. Hum Brain Mapp (2011) 1.45
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging (2004) 1.40
Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2012) 1.35
Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T. Magn Reson Med (2012) 1.33
Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum (2012) 1.32
Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am (2010) 1.31
Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry (2011) 1.31
Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci (2006) 1.30
In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull (2012) 1.28
In vivo quantitative proton MRSI study of brain development from childhood to adolescence. J Magn Reson Imaging (2002) 1.27
Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology (2002) 1.21
Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia. Arterioscler Thromb Vasc Biol (2009) 1.19
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17
Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging (2008) 1.16
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
Factors associated with work satisfaction of registered nurses. J Nurs Scholarsh (2006) 1.16
Variability in subcortical aphasia is due to variable sites of cortical hypoperfusion. Brain Lang (2004) 1.15
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging (2010) 1.14
High resolution spectroscopic imaging of GABA at 3 Tesla. Magn Reson Med (2010) 1.13
ATF4 regulates lipid metabolism and thermogenesis. Cell Res (2010) 1.12
Acceleration of 1H MR metabolic imaging with compressed sensing. Radiology (2013) 1.10
SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells. J Neurosci (2011) 1.10
Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med (2013) 1.10
Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging (2006) 1.09
Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging (2005) 1.08
17beta-estradiol activates estrogen receptor beta-signalling and inhibits transient receptor potential vanilloid receptor 1 activation by capsaicin in adult rat nociceptor neurons. Endocrinology (2008) 1.08
Subtraction artifacts and frequency (mis-)alignment in J-difference GABA editing. J Magn Reson Imaging (2012) 1.08
A simple model for understanding the origin of the amide proton transfer MRI signal in tissue. Appl Magn Reson (2012) 1.07
Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology (2003) 1.07
MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol (2011) 1.07
Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage (2013) 1.06
Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol (2003) 1.05
Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging (2009) 1.05
Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol (2010) 1.05
Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging (2004) 1.04
Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke (2002) 1.04
Broadband proton-decoupled proton spectra. Magn Reson Chem (2007) 1.04
Suppression of strong coupling artefacts in J-spectra. J Magn Reson (2005) 1.03
Double-balloon enteroscopy in small bowel tumors: a Chinese single-center study. World J Gastroenterol (2013) 1.03
Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J Neurosci (2010) 1.03
Optimized detection of lactate at high fields using inner volume saturation. Magn Reson Med (2006) 1.02
White matter alterations in deficit schizophrenia. Neuropsychopharmacology (2008) 1.02
MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol (2013) 1.01
Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging (2006) 1.01
Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry (2009) 1.00
Correction of symptomatic cerebral malperfusion due to acute type I aortic dissection by transcarotid stenting of the innominate and carotid arteries. J Vasc Surg (2006) 1.00
Identification and characterization of Dicer-like, Argonaute and RNA-dependent RNA polymerase gene families in maize. Plant Cell Rep (2011) 1.00
Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging. AJNR Am J Neuroradiol (2004) 0.99
A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med (2008) 0.99
Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011). J Thorac Dis (2012) 0.99
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia. Bioorg Med Chem Lett (2010) 0.98